Clene Inc. Capital Expenditures
Clene Inc. (CLNN) reported Capital Expenditures of $1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- Clene Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $28.00K, a 2700.00% increase year-over-year.
- Clene Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $11.00K, a 1000.00% increase year-over-year.
- Clene Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Clene Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Clene Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $39.00K, a 160.00% increase from fiscal 2024.
- Clene Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $15.00K, a 95.45% decline from fiscal 2023.
- Clene Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $330.00K, a 93.63% decline from fiscal 2022.
- Clene Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $5.18M, a 288.81% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $39.00K derived: sum of 2 quarters · filed 2026-03-17 | $39.00K derived: sum of 3 quarters · filed 2026-08-14 | $39.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.00K derived: sum of 2 quarters · filed 2026-08-14 | $11.00K 10-Q · filed 2025-11-13 | $12.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $1.00K derived: sum of 3 quarters · filed 2026-08-14 | $2.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $1.00K derived: sum of 2 quarters · filed 2026-03-17 | $2.00K derived: sum of 3 quarters · filed 2026-03-17 | $4.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.00K derived: sum of 2 quarters · filed 2026-03-17 | $4.00K derived: sum of 3 quarters · filed 2026-03-17 | $15.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.00K derived: sum of 2 quarters · filed 2025-11-13 | $14.00K 10-Q · filed 2025-11-13 | $57.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $13.00K 10-Q · filed 2025-08-14 | $56.00K derived: sum of 3 quarters · filed 2025-08-14 | $104.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $11.00K 10-Q · filed 2025-05-07 | $54.00K derived: sum of 2 quarters · filed 2025-05-07 | $102.00K derived: sum of 3 quarters · filed 2025-05-07 | $63.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $91.00K derived: sum of 2 quarters · filed 2025-03-24 | $52.00K derived: sum of 3 quarters · filed 2025-03-24 | $330.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $9.00K derived: sum of 2 quarters · filed 2024-11-13 | $287.00K 10-Q · filed 2024-11-13 | $1.99M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $239.00K 10-Q · filed 2024-08-07 | $1.94M derived: sum of 3 quarters · filed 2024-08-07 | $3.59M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $278.00K 10-Q · filed 2024-05-08 | $1.98M derived: sum of 2 quarters · filed 2024-05-08 | $3.63M derived: sum of 3 quarters · filed 2024-05-08 | $4.52M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.35M derived: sum of 2 quarters · filed 2024-03-13 | $4.24M derived: sum of 3 quarters · filed 2024-03-13 | $5.18M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.54M derived: sum of 2 quarters · filed 2023-11-07 | $3.48M 10-Q · filed 2023-11-07 | $4.15M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $888.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.82M 10-Q · filed 2023-08-14 | $2.50M derived: sum of 3 quarters · filed 2023-08-14 | $2.74M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $936.00K 10-Q · filed 2023-05-12 | $1.61M derived: sum of 2 quarters · filed 2023-05-12 | $1.85M derived: sum of 3 quarters · filed 2023-05-12 | $2.06M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $912.00K derived: sum of 2 quarters · filed 2023-03-13 | $1.13M derived: sum of 3 quarters · filed 2023-03-13 | $1.33M 10-K · filed 2023-03-13 |
| 2021-09-30 | $241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $458.00K derived: sum of 2 quarters · filed 2022-11-07 | $661.00K 10-Q · filed 2022-11-07 | $779.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $420.00K 10-Q · filed 2022-08-15 | $538.00K derived: sum of 3 quarters · filed 2022-08-15 | $613.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $203.00K 10-Q · filed 2022-05-09 | $321.00K derived: sum of 2 quarters · filed 2022-05-09 | $396.00K derived: sum of 3 quarters · filed 2022-05-09 | $567.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $193.00K derived: sum of 2 quarters · filed 2022-03-11 | $364.00K derived: sum of 3 quarters · filed 2022-03-11 | $387.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $246.00K derived: sum of 2 quarters · filed 2021-11-08 | $269.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $194.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $294.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |